The Struggle with Infectious Disease. Lecture 5

Similar documents
Viral Hemorrhagic Fevers

Media centre Ebola virus disease

Ebola Virus Disease (EVD) Essential information

UTSW/BioTel EMS TRAINING BULLETIN October EMS TB Ebola Virus Disease (EVD)

Genus Ebolavirus is 1 of 3 members of the Filoviridae family (filovirus), along with genus Marburgvirus and genus Cuevavirus.

CE Unit. Viruses and Vaccines

WHO SOUTHERN SUDAN HEALTH UPDATE May 2004

Yellow fever. Key facts

Where is Yellow Fever found?

EDUCATIONAL COMMENTARY EMERGING INFECTIOUS DISEASES WITH GLOBAL IMPACT

AOHS Global Health. Unit 1, Lesson 3. Communicable Disease

Ebola Virus Disease. Global Epidemiology and Surveillance in Hong Kong. as of 13 August 2014

The Ebola Virus. By Emilio Saavedra

CE Unit 7. Viruses and Vaccines

Today. Emerging Diseases. The concept of anti-ideas. Why new diseases appear Some specific examples. Vaccines

Making Sense Of The Ebola Virus

Ebola Virus Patient Advisory

Summary of current outbreak in Guinea, Liberia and Sierra Leone

EBOLA VIRUS AWARENESS

Vectors and Virulence

Fact sheet. Yellow fever

Invest in the future, defeat malaria

Ebola: 22,000 cases, 8700 deaths. Enterovirus D68: 1100 cases, 14 deaths. Chikungunya virus: almost a million cases in the Western Hemisphere

Repellent Soap. The Jojoo Mosquito. Africa s innovative solution to Malaria prevention. Sapphire Trading Company Ltd

World Health Day Vector-borne Disease Fact Files

Surveillance Protocol Dengue Fever (Breakbone fever, Dengue Hemorrhagic Fever)

EBOLA. Harford County Health Department October 22, 2014

Malaria. Population at Risk. Infectious Disease epidemiology BMTRY 713 (Lecture 23) Epidemiology of Malaria. April 6, Selassie AW (DPHS) 1

VIRAL HEMORRHAGIC FEVER (VHF)

DOWNLOAD OR READ : TROPICAL INFECTIOUS DISEASES SECOND EDITION PDF EBOOK EPUB MOBI

LECTURE topics: 1. Immunology. 2. Emerging Pathogens

Trypanosomiasis. Introduction. Epidemiology. Global Epidemiology. Trypanosomiasis Risk in UK Travellers

ZIKA VIRUS. John J. Russell MD May 27, 2016

Questions and Answers on Ebola

International Journal of Pharma and Bio Sciences A STUDY OF CLINCAL PROFILE IN DENGUE CASES ABSTRACT

Disease Transmission Methods

Ebola Virus Disease: the Facts, Response & the Way Forward. Dr. Abraham Idokoko Ebola Emergency Operations Centre (EEOC), Lagos.

U.S. and British troops head to West Africa to help fight Ebola virus

Malaria DR. AFNAN YOUNIS

Knowledge is power: 815 Second Avenue New York, NY Toll Free HEAL

Blood and Lymphatic Infections Lecture 24 Dr. Gary Mumaugh

saipem Ebola virus diseases EVD August 2014

Cholera. Ebola. Symptoms of Ebola include. Fever. Severe headache. Muscle pain. Weakness. Fatigue. Diarrhea. Vomiting. Abdominal (stomach) pain

EBOLA & OTHER VIRUSES IN THE NEWS EBOLA VIRUS, CHIKUNGUNYA VIRUS, & ENTEROVIRUS D68

INTERVENTION MODEL OF MALARIA

An Outbreak of Hemorrhagic Fever in Africa

Lecture 5: Dr. Jabar Etaby

Helminths in tropical regions

11/9/2017. New and Re-emerging Vector-Borne Diseases and the efforts to stop them through Mosquito Control

Create the Following Chart in your notebook. Fill in as you go through each one.

Mercer MRC A Newsletter for and about our volunteers

Dengue Virus-Danger from Deadly Little Dragon

Factsheet about Chikungunya

Mosquito Control Update. Board of County Commissioners Work Session February 16, 2016

Outline. Origin and Biogeography of Human Infectious Disease. Advantages of virulence. Diseases differ in virulence. Serial passage experiments

Ebola. Wessex CPD Event 14/11/14. Dr Ishani Kar-Purkayastha, CCDC, Wessex PHE Centre Tel:

Viral hemorrhagic fevers (VHFs) By : Assis. Prof Nader Alaridah MD, PhD

EBOLA INFORMATION KIT 20 to 26 October 2014 MEMBERS NEWS HUNTING SERVICES FUND LEGISLATION CALENDAR GENERAL SHOP POPULAR ARTICLES

CIRCULAR LETTER No

Case study: Epidemic modelling in real life

Health advice for travelers

David Bruce Conn. Berry College One Health Center Harvard University Museum of Comparative Zoology

Parasitic Protozoa, Helminths, and Arthropod Vectors

FYOS1001: Ecology of Infectious Diseases. Introduction to Mosquitoes as Vectors of Infectious Diseases

Annual Epidemiological Report

Is Climate Change Affecting Vector-borne Disease Transmission?

Palliative Care in Ebola

Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus

Suggested Exercises and Projects 395

EMERGING INFECTIOUS DISEASES DISCLOSURES EMERGING NONE

THE IMMUNE SYSTEM Chapter 40 (Miller & Levine)

Influenza B viruses are not divided into subtypes, but can be further broken down into different strains.

Epidemiology of Lassa Fever

Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive)

Ebola Virus Disease(EVD)

A BSL-1 lab houses activities that require only standard microbial practices. These include:

The Neglected Tropical Diseases of Guinea, Liberia, Sierra Leone

When infections go viral Zika Virus

Leishmaniasis, Kala Azar(The Black Fever)

General Description. Significance

UNDERSTANDING ZIKA AND MOSQUITO BORNE ILLNESSES

Epidemic Ebola Virus Disease Understanding, demystifying and controlling a frightening disease Republic of Guinea, 2014

NTDs Slated for Elimination and Eradication

Acute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).

BOVA Network - Building Out Vector-borne diseases in sub-saharan Africa. First BOVA Open Network Meeting IEDE-UCL, London, 28 th March 2018

Mosquito Control Matters

Both Hosts become infected Some viruses very specific in host-vector relationship Some very generalist

Immune System. Before You Read. Read to Learn

Fever virus going around 2017

12 June The average EVD case fatality rate has been around 50 per cent.

Malaria and Global Warming. Jocelyn Maher & Mickey Rowe

Downloaded from

Advisory on Plague WHAT IS PLAGUE? 19 October 2017

malaria epidemics FD90C2A80F37419F A1B6C58 Malaria Epidemics 1 / 6

Marburg and Lassa viruses ศาสตราจารย ดร.พ ไลพ นธ พ ธว ฒนะ

Global Climate Change and Mosquito-Borne Diseases

Confronting Ebola. Keeping NY patients and healthcare workers safe and healthy

Blood Smears Only 6 October Sample Preparation and Quality Control 15B-K

MASS TREATMENT COVERAGE FOR NTDS Democratic Republic of the Congo and neglected tropical diseases

Ebola Virus Disease. What the physician needs to know. (Overview, Transmission and Clinical Features)

Transcription:

The Struggle with Infectious Disease Lecture 5

Tropical Diseases Life and infectious disease began in the rift valley/rain forest of Eastern Africa Peoples migrated North to temperate regions

Tropical Diseases Diseases that thrive in a hot, humid climate Sometimes extended to hot regions eg sub-sahara Types of infections more common in these areas: More complex life forms Soil or water stages More complex stages in insects (no over-winter problem)

WHO identifies the most common tropical diseases as: Malaria, Leishmaniasis Schistosomiasis Onchocerciasis Lymphatic filariasis Chagas disease African trypanosomiasis Dengue. Tropical Diseases

Tropical Diseases Types of disease Single cell parasites Single/multi-cell parasites Nematodes Worms Virus/bacteria

Cost of Tropical Diseases Difficult to accurately compute Impact on agricultural work (30% decrease for some single diseases) Impact on school attendance Estimated cost of Trachoma $1.5 billion/yr

Cost of Tropical Diseases Generally chemotherapy medications are inexpensive $0.50 - $0.05

Malaria A parasitic disease Caused by single cell organism plasmodium 4 types that infect people (~16 total) Spread by Anopheles mosquito

Malaria: why we should care Common in tropical and sub-tropical regions around the world Residents develop some level of immunity Naive hosts react much more severely Treatment options are limited

Malaria: why we should care 300 to 500 million cases per year (WHO) Over 1 million deaths per year annually 85% of deaths are children under the age of 5 90% of deaths are in Africa

Outside Africa malaria is concentrated in 8 countries in SE Asia Malaria

Symptoms High fever Shaking chills Flu-like symptoms Anemia Symptoms usually occur within 10 days to 4 weeks (up to 1 year) Symptoms last 48 72 hours (recurrent) Malaria

Malaria Death is usually due to anemia due to burst blood cells Plasmodium falcparum is the most serious and can lead to death within hours of the first symptoms

Malaria Disease is transmitted from person to person by mosquito Separate life stages in people and insect Three distinct life stages First: Injected by mosquito into blood stream and migrate to liver and multiply

Rupture kidney cell and enter blood stream Second: parasite infects red blood cell (erythrocyte) and multiples over ~ 48 hours Red cell ruptures releasing further parasites Malaria

Malaria Two types of reproduction take place Asexual (more efficient) Gametes (evolutionary) Parasites are returned to mosquito through a blood meal Third: parasite reproduces in mosquito

Treatment: Drug treatments can only be effective when parasite in not hiding in another cell Drug resistance has developed In part due to incomplete treatment of infection Multi-drug treatments are currently being used successfully Malaria

Malaria Prevention Prevention becomes key strategy Mosquito control Mosquitos have become insecticide resistant Mosquito habitat control Mosquito bite control Bed net programs Vaccines have been unsuccessful

Malaria Prevention Mosquito control Mosquitos have become insecticide resistant Mosquito habitat control

Malaria Prevention Mosquito bite control Bed net programs

Reduction in deaths since 2000 by 25% worldwide and 33% in Africa Malaria Prevention

Malaria Vaccine Development Possibilities (Pro) Plasmodium is in the size range where the immune system functions well It is a single cell organism in all stages Issues (Con) Plasmodium more complex than bacteria or virus Life cycle complex, many stages and forms Sexual & asexual Reproduction rate in blood borne stage greatly exceeds the need for survival Have to kill off nearly all

Malaria Vaccine Development Potential targets for vaccine: Pre-erythrocyte Blood stage Transmission blocking Currently 41 vaccines under development

One vaccine has made it to phase 3 clinical trial Has proved somewhat effective ~30% - 50% Less effective in young children (where it is most needed) than in older children We are not there yet

Dengue Fever Also know as Breakbone Fever Viral infection with 4 serotypes Transmission by mosquito Aedes aegypti Widely distributed throughout the world Also spread Yellow Fever and Chikungunya

Developed in monkeys Jumped to humans in Africa/SW Asia 100-800 years ago Second world war transported mosquito and disease around the world 100 million infected annually Dengue Fever

Dengue Fever

Dengue Fever

Dengue Fever Symptoms Symptoms start 3-10 days after bite Skin rash High fever: 104-105 for 4-7 days Febrile seizures: can be extremely severe hence the name breakbone fever Usually resolves after 10 days

Dengue Fever No vaccine available No treatment Prevention has been partially successful

Dengue Fever Prevention

Dengue Hemorrhagic Fever 4 Serotypes of Dengue Infection with one serotype does not provide immunity to other three In fact infection with a second serotype is much more serious

Dengue Hemorrhagic Fever Symptoms: Similar course to Dengue Fever But with fever shock-like symptoms develop Crisis period lasts 1 day Bleeding occurs in patches under the skin Sometimes bleeding from nose & mouth

Dengue Hemorrhagic Fever Shock-like symptoms develop Can cause death 100,000 deaths each year due to Dengue and Dengue Hemorrhagic Fever Increased capillary permeability and reduced clotting ability are believed to be due to over-reaction of the immune system Antibody-dependent Enhancement (ADE)

Dengue Fever is one of the fastest spreading (geographically) vector borne infectious diseases Cases have been reported in Southern Texas (2005) Endemic throughout Caribbean Dengue Fever

Dengue Fever Range could be impacted by climate change Dengue seems to be more ubiquitous than yellow fever

Ebola Virus Ebola, previously known as Ebola hemorrhagic fever, is a rare and deadly disease caused by infection with one of the Ebola virus strains. Ebola can cause disease in humans and nonhuman primates (monkeys, gorillas, and chimpanzees). Ebola is caused by infection with a virus of the family Filoviridae, genus Ebolavirus. There are five identified Ebola virus species, four of which are known to cause disease in humans: Ebola virus (Zaire ebolavirus); Sudan virus (Sudan ebolavirus); Taï Forest virus (Taï Forest ebolavirus, formerly Côte d Ivoire ebolavirus); and Bundibugyo virus (Bundibugyo ebolavirus). The fifth, Reston virus (Reston ebolavirus), has caused disease in nonhuman primates, but not in humans. Ebola viruses are found in several African countries. Ebola was first discovered in 1976 near the Ebola River in what is now the Democratic Republic of the Congo. Since then, outbreaks have appeared sporadically in Africa. The natural reservoir host of Ebola virus remains unknown. However, on the basis of evidence and the nature of similar viruses, researchers believe that the virus is animal-borne and that bats are the most likely reservoir. Four of the five virus strains occur in an animal host native to Africa. CDC Atlanta, USA

5 known Ebola viruses 4 infect humans Clinically almost identical to Marburg virus First recorded epidemic: August 26, 1976 in Yambuku on the Ebola River DRC Zaire EBOV Ebola Virus

May have the highest case mortality of any known disease: 90% in some epidemics; 83% overall With treatment as low as 50% Sporadic outbreaks in remote villages usually in or near to rainforest Ebola Virus

Ebola Virus Fruit bats are considered the natural host Contact with blood, secretions, organs or other body fluids Chimps, gorillas, monkeys, forest antelope, porcupines

Ebola Virus Human to human transmission through infected tissue of fluids Family members Funerals Health care workers (poorly protected) Transmission via infected serum can occur up to 7 weeks

Host immune responses to Ebola virus and cell damage due to direct infection of monocytes and macrophages cause the release of cytokines associated with inflammation and fever (A). Sullivan N et al. J. Virol. 2003;77:9733-9737

Ebola Virus

Ebola Virus Symptoms 2 21 days following infection Stage 1: fever, intense weakness, muscle pain, headache, sore throat Stage 2: vomiting, diarrhoea, rash impaired kidney function, internal & external bleeding Infectious up to 61 days

Ebola Virus Virus enters monocytes in the blood stream and multiplies Breakup of cells causes cytokine response (fever, inflammation) Endothelial cells, hepatocytes are targets Death of endothelial cells causes blood leakage ad clotting problems

Ebola Outbreak 2014

Ebola Outbreak 2014

Fighting Ebola Support the patient so that the immune system can fight the virus Improve the immune system convalescent serum Anti-viral When will it work? Vaccines Why is it taking so long?

Above all Prevent spread of the virus How many times in history, how many diseases Increase understanding of disease transmission How many theories Education to overcome cultural beliefs What other cultural beliefs

Have we come so far?

Supplementary Material

Leishmaniasis Single cell parasite Transmitted by sand fly Person to person or mammal to person (dog, rodent) 20 species of parasite 30 species of sand fly Range: S America, Africa Occasionally Texas Cutaneous 0.7 to 1.2 mm sores 1.2 million cases/year Visceral Spleen, liver, kidney, bone marrow 400,00 cases/year Life threatening Difficult to treat

Schistosomiasis Second most devastating parasitic disease 280,00 deaths/yr Parasitic worm Reservoir: freshwater snails Fecal/urinary transmission of eggs to water Penetrates skin & reproduces in blood stream Symptoms are due to the reaction to the eggs Inflammation/scaring in bladder and small intestine 1-2 months following infection Skin reaction within days Chronic symptoms: Enlarged liver, abdominal pain, intestinal/urinary, growth, mental capcity Medication is available (1-2 day treatment)

Onchocerciasis (River Blindness) Parasitic worm (nematode) Transmitted by black flies: Larvae develop in black fly 37 million infected Two stages: Transmissible 200-400µ Resident 30-50cm long Treatable with medication For lifetime of worm (15yr) New med attacks bacterial food source Live in nodules under the skin for <15yr May not induce immune response Respond to dead larvae 1000/day per nematode Blotchy skin Reversible corneal/optic nerve damage

African trypanosomiasis (Sleeping Sickness) Single cell parasite (rather like malaria) Spread by Tetsi fly Largely human reservoir (some animals) Endemic in rural Africa 10,000 cases/yr Multiplies in body fluids (blood,lymph,spinal fluid) Second stage crosses blood/brain barrier Leads to neuro problems

Chagas Transmission through feces of kissing bug Enters through skin or wound Enters tissue near wound and differentiates Gametes multiply by binary fusion Does not differentiate in blood stream Central and South America Acute phase: immediate to several months Mild/asymptomatic, swelling Chronic stage No parasites in blood Asymptomatic Complications: Heart rhythm (sudden death) Dilated heart, esophogus/colon